The Global Cell Surface Markers Market is projected to grow at a CAGR of 7.4% from USD 609.2 Million in 2020 to USD 1.07 Billion in 2030.
The Global Cell Surface Markers Market is projected to grow at a CAGR of 7.4% from USD 609.2 Million in 2020 to USD 1.07 Billion in 2030. Cell surface markers are useful in research activities for determining the effect of drugs. It is also an effective means for providing personalized medication because, with the help of cell surface markers, physicians can analyze cell isolation of the care user and provide with the necessary therapy.
CD markers, t cell surface markers, cluster of differentiation in immunology, t cell markers flow cytometry, T cell marker immunohistochemistry, T cell immunophenotyping, cell membrane, lymphocyte markers, cluster of differentiation, and others are some of the most concerned topics that the end-use verticals and companies extensively focusing on. Lymphocytes percentage, lymphocytes absolute are a few instances of emphasize for the continuous innovations.
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118300
Cell surface markers, which is a type of protein, are usually found on the surface of specific cell types. With the help of this protein, a particular kind of cells can be identified and categorized.
In recent years, the cell surface markers market is experiencing significant growth. The combination of different factors drives market growth. One of the mentionable driving factors is the rise in the occurrence rate of cancer and other autoimmune diseases. Such an increase in the occurrence rate of cancer has stimulated the demand for developing simple disease identification solutions and automatize it. Hence, the rise in the occurrence rate of autoimmune diseases is positively impacting the growth of the market. It is mentionable here that the increase in the occurrence rate of diseases like cancer is also increasing the disease burden on occurring nations that have resulted in an increased emphasis on minimizing the disease diagnosis cost. This emphasis on reducing disease diagnosis cost is positively impacting the cell surface markers market because it is an effective and economical means of identifying such autoimmune health conditions. In addition to the mentioned factor, in recent years, there has also been a raised expenditure on technological advancements in the healthcare sector. The rise in healthcare technological advancements is also boosting the growth of the market.
North America is observed to be dominating the market. This region’s market dominance is the result of the rise in the use of cell surface markers in personal medication, increased number of R&D activities, and elevated emphasis on drug development and discovery.
Key players are emphasizing on collaborations with other entities present in the market like academic research institutions and laboratories, focusing on their R&D for producing cell-specific antibodies. Such efforts are made by the key players to penetrate the untapped market and retain its market position.
Cell Type Outlook:
In regards to the cell type, the T Cell Surface Markers segment can be seen to dominate the market that occupied 38% of the market in 2018 with a CAGR of 7.9% during the forecast period. The proliferation and activation of T cells at the time of infections and its effectiveness in identifying the antigens that get introduced in the body by histocompatibility and complex help in infection identification. Hence the increased number of infections and rise in the number of researches being conducted in the particular field is contributing to this segment’s market share.
End-Users Outlook:
In context to end-users, the market is led by the Academic & Research Institutes segment that held the largest market share of 48% in 2018 with a growth rate of 7.8% during the forecast period. Factors resulting in the market dominance of this segment is the result of the increased number of researches for drug discovery and elevated emphasis on identifying novel drug targets for chronic conditions.
Application Type Outlook:
In regards to application, the Research Applications segment can be seen to be dominating the market that occupied a market share of 65.3% in 2020 with a growth rate of 7.1% during the forecast period. The market dominance of this segment has been the result of the rise in use of cell surface markers in stem cell, cancer, and HIV care, the associated growth in cell surface marker-based research and increased private and public funding in these researches.
Related Reports:
- Blood Preparation Market: https://qyresearchmedical.com/report/blood-preparation-market-size-share-and-analysis-by-product-type-whole-blood-blood-components-blood-derivatives-by-antithrombotic-and-anticoagulant-type-platelet-aggregation-inhibitors-fibrinolytics-antico-st-to-2030/118255
- Live Cell Encapsulation Market: https://qyresearchmedical.com/report/live-cell-encapsulation-market-size-share-and-analysis-by-technique-simple-dripping-electrostatic-dripping-liquid-jet-break-up-coaxial-airflow-vibrating-jet-jet-cutting-by-polymer-alginate-chitosan-sili-st-to-2030/118254
Regional Outlook:
In context to region, North America can be seen to lead the market that occupied, 36% of the market in 2018 with a CAGR of 7.9% during the forecast period. The increased occurrence rate of cancer and the rise in the number of research projects being conducted in this region is contributing to its market share.
Europe is another major region for this market, which follows North America in context to its market share. The presence of market leaders in this region is one of the major contributing factors for its market share.
In the global cell surface markers market, the Asia Pacific region is forecasted to witness the highest growth rate of 8.9% during the forecast period. The growth rate of this region has been driven by a significant rise in investments for R&D in the healthcare sector and unmet healthcare and medical needs.
Market-O-Nomics
- There have been significant advancements in the recent years, in the techniques and high-throughput tools that are required for cytological evaluation. Such advancements in the cytological evaluation are boosting the growth of the cell surface markers market.
- In regards to the products, the Antibodies segment can be seen to lead the market that yielded the higher revenue in 2020 with the higher growth rate of 7.9% during the forecast period. The revenue yielded by this segment has been attributed to the increased number of neurobiology researches that requires reliable and accurate antibodies.
- In the context of source, the Mice segment generated the highest revenue Million in 2020 with the highest growth rate of 8.0% during the forecast period. This source is one of the most cost-effective sources for antibody production, which is a significant reason for the growth rate of this segment.
- In the global cell surface markers market, the Asia Pacific region is forecasted to witness the highest growth rate of 8.9% during the forecast period. The growth rate of this region has been driven by a significant rise in investments for R&D in the healthcare sector and unmet healthcare and medical needs.
Companies considered and profiled in this market study
Janssen Diagnostics, Inc, Thermo Fisher Scientific, Inc., Siemens Healthcare, Nihon Kohden Corporation, Bio-Techne, Genscript, F. Hoffman-La Roche, Danaher Corporation, Thermo Fisher Scientific, Abcam, Becton, Dickinson and Company, Qiagen N.V., among others are leading players involved on the global Cell Surface Markers market.
Start-up Traction
The Cell Surface Markers Market industry poses significant amount of opportunities for small manufacturers and startups to come up with cost-effective solutions in manufacturing of Cell Surface Markers products. Many innovative start-ups that are growing remarkably have been profiled in the report with all their innovative techniques and developments. There is a continuous growth in demand from the end-users, which can encourage several startups to launch innovative products in this market.
Deals Landscape
Mergers and Acquisitions are an integral part of this industry. These mergers and acquisitions help us decide the strategic initiatives taken up by the leading players as well as growing companies dealing in this market, and have been included in this report.
Expert Insights:
Reports and Data forecasts in the Cell Surface Markers industry having considered the interviews with some of most the prestigious personalities and experts in this market. According to the industry experts, CD markers, t cell surface markers, cluster of differentiation in immunology, T cell markers flow cytometry, T cell marker immunohistochemistry, T cell immunophenotyping, cell membrane, lymphocyte markers, cluster of differentiation, and others are some of the most concerned topics that the end-use verticals and companies extensively focusing on. Lymphocytes percentage, lymphocytes absolute are a few instances of emphasize for the continuous innovations.
Segments covered in the report
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020 to 2030. The scope of the report can be defined as:
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118300
For the purpose of this report, Reports and Data have segmented the global cell surface markers market based on Cell Type, Product, Source, Instrument, and Reagent Type, Application, End-users, and Region:
Cell Type Outlook (Revenue: USD Million; 2020-2030)
- T Cell Surface Markers
- NK Cell Surface Markers
- B Cell Surface Markers
- Monocyte Cell Surface Markers
- Others
Product Type Outlook (Revenue: USD Million; 2020-2030)
- Antibodies
- Pcr Arrays
Source Type Outlook (Revenue: USD Million; 2020-2030)
- Rats
- Mice
- Others
Instrument and Reagent Type Outlook (Revenue: USD Million; 2020-2030)
- Flow Cytometer
- Reagents and Kits
- Hematology Analyzers
Application Type Outlook (Revenue: USD Million; 2020-2030)
- Research Applications
- Drug Discovery
- Stem Cell Research
- Immunology
- Medical Applications
- Oncology
End-users Type Outlook (Revenue: USD Million; 2020-2030)
- Clinical Testing Laboratories & Hospitals
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
Regional Outlook (Revenue: USD Million; 2020-2030)
- North America
- U.S
- Canada
- Europe
- Germany
- U.K
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of APAC
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
- Latin America
- Brazil
- Rest of LATAM
Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118300/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL - http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/
https://twitter.com/qyresearchmedi